Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Etoricoxib (90mg) + Paracetamol (325mg) Tablet
Therapeutic Category
Anti-Inflammatories, Antispasmodic
Dosage Form
Packaging Type
Packaging
Price
₹/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Some patients may experience nausea, acidity, abdominal discomfort, dizziness, headache, or swelling. Rarely, liver-related complications, gastrointestinal bleeding, kidney dysfunction, or allergic reactions may occur and require medical attention.
Etoscrib P 90 Tablet is indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, musculoskeletal pain, dental pain, postoperative pain, and other inflammatory painful conditions. It helps relieve pain, reduce swelling, improve mobility, and lower fever.
This medicine should be used under medical supervision. Avoid exceeding the recommended dosage due to the presence of Paracetamol. Use cautiously in patients with heart disease, liver disorders, kidney disease, or gastrointestinal conditions. Avoid alcohol consumption during treatment.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Etodolac (600mg)
Composition : Etoricoxib (60mg) Tablet
Composition : Etoricoxib (90mg) Tablet
Composition : Nimesulide (100mg) MD Tablet
Composition : Piroxicam (20mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Composition : Diclofenac (50mg) + Serratiopeptidase (10mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Etoscrib P 90 Tablet has strong demand in the pain management and anti-inflammatory segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on orthopedic and general medicine portfolios.
Medical distributors and agencies can benefit from consistent demand for management of joint pain, arthritis, back pain, muscle pain, post-operative pain, dental pain, and inflammatory conditions. Etoricoxib 90mg is a selective COX-2 inhibitor that helps reduce pain and inflammation effectively Paracetamol 325mg provides additional pain relief and fever reduction support Together, they provide effective and long-lasting relief from painful inflammatory conditions, strengthening a reliable pain-management portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Etoscrib P 90 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong orthopedic and physician prescriptions, high demand in pain-management therapy, fast retail movement, reliable supply chain support, and good margins in analgesic and anti-inflammatory medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.